Is there more you can do to
help improve your lung function
so you can breathe better?*

ADVAIR may help if you have COPD, including chronic bronchitis, emphysema, or both. ADVAIR helps significantly improve lung function so you can breathe better. ADVAIR is different from most medications because it contains both an anti-inflammatory and a long-acting bronchodilator working together to help you breathe better.

Important Safety Information About ADVAIR DISKUS 250/50

ADVAIR DISKUS 250/50 is approved for adults with COPD, including chronic bronchitis, emphysema, or both. You should only take 1 inhalation of ADVAIR twice a day. Higher doses will not provide additional benefits. People with COPD taking ADVAIR may have a higher chance of pneumonia. Call your doctor if you notice any of the following symptoms: change in amount or color of sputum, fever, chills, increased cough, or increased breathing problems.

ADVAIR may increase your risk of osteoporosis and some eye problems (cataracts or glaucoma). You should have regular eye exams. Thrush in the mouth and throat may occur. Tell your doctor if you have a heart condition or high blood pressure before taking ADVAIR. Do not use ADVAIR with long-acting beta2-agonists for any reason. ADVAIR does not replace fast-acting inhalers for sudden symptoms.

Complete Prescribing Information and Medication Guide for ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder).

ADVAIR DISKUS is convenient to use.   Help improve lung function

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

* ADVAIR 250/50 is clinically proven to significantly improve lung function (measured by a breathing test), compared with people taking either fluticasone
  propionate 250 mcg or salmeterol 50 mcg (inhalation powders). Your results may vary.

It is not known how anti-inflammatories work in COPD.

Subject to eligibility. Restrictions apply.

GSK Corporation    GSK For You    Contact Us

This website is funded and developed by GlaxoSmithKline.
This site is intended for US residents only.
© 1997-2010 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Medicine Savings | Contact Us